Quantcast

Latest Alzheimer's disease Stories

2014-09-16 23:05:58

Detection, at the Icahn School of Medicine at Mount Sinai, while the patient is still alive improves accuracy of diagnosis and enables estimation of prevalence and risk. New York, NY (PRWEB) September 16, 2014 An experimental positron emission tomography (PET) tracer is effective in diagnosing concussion-related brain disease while a person is still alive, according to a case study conducted at the Icahn School of Medicine at Mount Sinai, and at Molecular Neuroimaging (MNI) LLC in New...

2014-09-16 12:31:21

DementiaWise Seminar to Provide Valuable Tips to Families with Loved Ones Suffering From Dementia CHERRY HILL, N.J., Sept. 16, 2014 /PRNewswire/ -- According to the Alzheimer's Association, by the time 1 in 3 seniors pass away, they will have been afflicted with Alzheimer's disease or another form of dementia. Dementia, a term used to describe a number of cognitive diseases which impair mental functions, can be debilitating for sufferers and heartbreaking for their loved ones. On...

2014-09-16 08:29:21

INDIANAPOLIS, Sept. 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and AstraZeneca today announced an agreement to co-develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease. The progression of Alzheimer's disease is characterized by the accumulation of amyloid plaque in the brain. BACE is an enzyme associated with the development of beta-amyloid. Inhibiting BACE...

2014-09-15 08:29:32

- Significantly Improved Agitation in 220-Patient 10-week Study - ALISO VIEJO, Calif., Sept. 15, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced positive results from its phase II clinical trial evaluating the safety and efficacy of AVP-923 for the treatment of agitation in patients with Alzheimer's disease. Treatment with AVP-923 was associated with significantly reduced agitation as measured by the primary endpoint, the agitation/aggression...

NFL cognitive impairments
2014-09-15 05:39:54

Chuck Bednar for redOrbit.com - Your Universe Online Documents filed by lawyers representing the National Football League (NFL) acknowledge that at least one-fourth of players are likely to wind up suffering from dementia, Alzheimer's disease, Parkinson's disease or other cognitive impairments after their careers are over, various media outlets are reporting. According to Reuters reporter Brendan O'Brien, the filing is a summary of the results of an actuarial study which it had...

2014-09-11 23:12:56

A promising first-in-class drug that stimulates the creation of new nerve cells in the brains of "Alzheimer's mice," will soon be tested in the brains of human patients with the promise it can help people in the early stages of the disease, based on research funded by the Cure Alzheimer's Fund. Boston, MA (PRWEB) September 11, 2014 A promising first-in-class drug that stimulates the creation of new nerve cells in the brains of "Alzheimer's mice," will soon...

2014-09-11 12:26:44

Leading researchers and industry experts discuss how to accelerate the development of new treatments and technologies to improve the lives of people with dementia and their families and caregivers OTTAWA, Sept. 11, 2014 /CNW Telbec/ - The Honourable Rona Ambrose, Canada's Minister of Health, and Mr. Philippe Zeller, Ambassador of France to Canada, today welcomed leading dementia researchers and industry experts from G7 countries to Ottawa for the Canada-France Global Dementia Legacy Event....

sedative alzheimers link
2014-09-11 05:22:28

Chuck Bednar for redOrbit.com - Your Universe Online Benzodiazepine, a sedative that is widely prescribed to treat people suffering from anxiety and insomnia, have been linked to a 50 percent increase in the risk of Alzheimer's disease, a team of French and Canadian researchers reported Tuesday in the online edition of the journal BMJ. In the study, lead investigator Sophie Billioti de Gage of the University of Bordeaux and her colleagues looked at nearly 2,000 cases of Alzheimer’s...

2014-09-10 23:09:26

Alzheimer Society of Ontario excited to participate in novel assistive-technology effort Toronto (ON) September 10, 2014 (PRWEB) September 10, 2014 The Alzheimer Society of Ontario is excited to be part of a novel effort to develop assistive technology for people with dementia. From 12-14 September, technological innovators will convene at the Toronto dementia hackathon to tackle the most pressing challenges faced by caregivers and people with dementia, and invent… on the spot…...

2014-09-10 16:26:25

The Congressman met with Dr. Dennis Gillings and a delegation from the World Dementia Council, an advocacy body created to stimulate innovation and the development of drugs, treatment and care for patients suffering from dementia WASHINGTON, Sept. 10, 2014 /PRNewswire-USNewswire/ -- Congressman Chaka Fattah (D-PA) met today on Capitol Hill with Dr. Dennis Gillings, head of the World Dementia Council, to advance their joint mission to find cures, treatments, and new drugs that will...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'